Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001579536 | SCV001818756 | likely benign | not provided | 2021-01-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001579536 | SCV002497400 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | TNXB: BP4, BP7, BS2 |
Genome Diagnostics Laboratory, |
RCV002276814 | SCV002565199 | likely benign | Ehlers-Danlos syndrome | 2021-09-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002386471 | SCV002695699 | benign | Cardiovascular phenotype | 2019-03-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001579536 | SCV001807604 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579536 | SCV001927213 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579536 | SCV001972089 | likely benign | not provided | no assertion criteria provided | clinical testing |